Filter Results:
(4,962)
Show Results For
- All HBS Web
(4,962)
- People (16)
- News (1,906)
- Research (2,472)
- Events (2)
- Multimedia (221)
- Faculty Publications (1,885)
Show Results For
- All HBS Web
(4,962)
- People (16)
- News (1,906)
- Research (2,472)
- Events (2)
- Multimedia (221)
- Faculty Publications (1,885)
- 15 Apr 2014
- News
Bertarelli Foundation Gift Names Deans' Health & Life Sciences Challenge Prize
accelerate the development of innovative solutions and help position Harvard University as the preeminent institution in health care and life sciences," said Dean Nohria. "With the generous support of the... View Details
- August 2012 (Revised August 2014)
- Case
Cancer Treatment Centers of America® (A)
By: Regina E. Herzlinger and Natalie Kindred
Cancer Treatment Centers of America (CTCA), a U.S. network of four privately owned oncology focused factory hospitals, was weighing options for growth. CTCA was entirely cancer focused and specialized in treating patients with complex and advanced-stage cancers, who... View Details
Keywords: Cancer; Cancer Treatment; Health Care; Healthcare; Accountability; Outcomes; Outcomes Measurement; Outcomes Reporting; Hub And Spoke Cancer Care; Hub And Spoke; Hub-and-spoke; Focused Factory; Mission and Purpose; Private Ownership; For-Profit Firms; Health Disorders; Medical Specialties; Policy; Business Model; Expansion; Decision Choices and Conditions; Advertising; Health Care and Treatment; Innovation and Invention; Health Industry; United States
Herzlinger, Regina E., and Natalie Kindred. "Cancer Treatment Centers of America® (A)." Harvard Business School Case 313-012, August 2012. (Revised August 2014.)
- 08 Feb 2022
- Blog Post
Get to Know Past New Venture Competition Winners: Everly Health
and their time at HBS helped shape their entrepreneurial journey. Alumni Track: Julia Cheek (MBA 2011), CEO and Founder, Everly Health What inspired you to start your company or organization? I started my company to create a better... View Details
- 03 Feb 2023
- News
How Managers Can Address Their Own Biases Around Mental Health
- November–December 2015
- Article
Active Postmarketing Drug Surveillance for Multiple Adverse Events
By: Joel Goh, Margrét V. Bjarnadóttir, Mohsen Bayati and Stefanos A. Zenios
Postmarketing drug surveillance is the process of monitoring the adverse events of pharmaceutical or medical devices after they are approved by the appropriate regulatory authorities. Historically, such surveillance was based on voluntary reports by medical... View Details
Keywords: Drug Surveillance; Health Care; Stochastic Models; Queueing; Diffusion Approximation; Brownian Motion; Health Care and Treatment; Analytics and Data Science; Analysis
Goh, Joel, Margrét V. Bjarnadóttir, Mohsen Bayati, and Stefanos A. Zenios. "Active Postmarketing Drug Surveillance for Multiple Adverse Events." Operations Research 63, no. 6 (November–December 2015): 1528–1546. (Finalist, 2012 INFORMS Health Applications Society Pierskalla Award.)
- Web
The Institute for Cancer Care Innovation - Institute For Strategy And Competitiveness
Michael Porter and his work to promote value-based health care delivery in the U.S. health care system. By leveraging the experience of both... View Details
- 24 Feb 2022
- Other Presentation
The Fearless ICU
By: Amy C. Edmondson
The last 24 months have pushed ICU teams around the world to their limits. As we move forward, we need to heal and rebuild our critical care teams. Healthcare more than ever will require ICU teams to perform at the highest levels and to continuously innovate to deliver... View Details
Keywords: Psychological Safety; Teams; Critical Care; Health Care and Treatment; Groups and Teams; Performance Effectiveness
"The Fearless ICU." Critical Matters (podcast), Sound Physicians, February 24, 2022.
- April 24, 2023
- Article
In the COVID Era, Why Corporate Benefits Demand CEO/CFO Leadership
The expectation that employers provide their employees’ health benefits has been around since World War II. Unfortunately, although today’s employees expect employers to treat them as individuals, ease their experiences, prioritize their wellbeing, and control cost,... View Details
Keywords: COVID; COVID-19 Pandemic; CEO; Leadership; Health Insurance; Benefits; CFO; Compensation and Benefits
Herzlinger, Regina E. "In the COVID Era, Why Corporate Benefits Demand CEO/CFO Leadership." CMR Insights (April 24, 2023).
- October 2013
- Case
FasterCures: Removing Barriers to Treatments
By: Richard G. Hamermesh and James Weber
In mid-2013, as FasterCures celebrated its 10th anniversary as a center of the Milken Institute, Executive Director Margaret Anderson thought about what the organization should do to ensure it had even more impact in its next 10 years. FasterCures was a non-profit... View Details
Keywords: Health Care; Health Care Industry; Health Care Policy; Health Services; Healthcare; Healthcare Reform; Healthcare Ventures; Nonprofit; Non-profit Management; Not-for-profit; Incubator; Accelerator; Venture Philanthropy; Medical Services; Medical Solutions; Medical Research; Medical Treatment; Clinical Trials; Drug Reimbursement; Early Stage; Early Stage Research Funding; Early Stage Funding; Milken Institute; Michael Milken; David Baltimore; Partnering For Cures; National Institutes Of Health; Cancer Care In The U.S.; Cancer Care Services; Policy-making; Health Care and Treatment; Health; Health Testing and Trials; Entrepreneurship; Social Entrepreneurship; Nonprofit Organizations; Policy; Health Industry; United States; District of Columbia
Hamermesh, Richard G., and James Weber. "FasterCures: Removing Barriers to Treatments." Harvard Business School Case 814-003, October 2013.
- 09 Nov 2009
- News
Why Health Reform Will Be a Danger to Passive Patients
- 2004
- Class Lecture
Consumer-Driven Health Care: A Revolution for Employers, Consumers, and Providers
Herzlinger, Regina E. "Consumer-Driven Health Care: A Revolution for Employers, Consumers, and Providers." Boston: Harvard Business School Publishing Class Lecture, 2004. Electronic. (Faculty Lecture: HBSP Product Number 5992C.)
- November 2022 (Revised March 2024)
- Case
Replika AI: Monetizing a Chatbot
By: Julian De Freitas and Nicole Tempest Keller
In early 2018, Eugenia Kuyda, co-founder and CEO of San Francisco-based chatbot Replika AI, was deciding how to monetize the app she had built. Launched in 2017, Replika was a consumer AI “companion app” developed by a team of AI software engineers originally based in... View Details
Keywords: Mental Health; Subscriber Models; TAM; Monetization Strategy; Marketing Strategy; Product Marketing; AI and Machine Learning; Applications and Software; Product Positioning; Health Disorders; Technology Industry
De Freitas, Julian, and Nicole Tempest Keller. "Replika AI: Monetizing a Chatbot." Harvard Business School Case 523-016, November 2022. (Revised March 2024.)
- 2013
- Working Paper
Work Design Drivers of Organizational Learning about Operational Failures: A Laboratory Experiment on Medication Administration
By: Anita L. Tucker
Operational failures persist in hospitals, in part because employees work around them rather than attempt to prevent recurrence. Drawing on a process improvement tool—the Andon cord—we examine three work design components that may foster improvement-oriented behaviors:... View Details
Keywords: Health Care; Process Improvement; Organizational Learning; Behavioral Operations; Prosocial Behavior; Experiments; Organizational Change and Adaptation; Behavior; Performance Improvement; Health Care and Treatment; Business Processes; Health Industry
Tucker, Anita L. "Work Design Drivers of Organizational Learning about Operational Failures: A Laboratory Experiment on Medication Administration." Harvard Business School Working Paper, No. 13-044, November 2012. (Revised September 2013.)
- September 2020 (Revised January 2021)
- Case
Catalys Pacific
In 2019, BT Slingsby founds Catalys Pacific, the first biotech “venture creation” fund in Tokyo. After convincing some of the biggest Japanese pharmaceutical firms to invest, BT hopes the fund can make a big splash and transform biotechnology innovation in Japan. After... View Details
Keywords: Pharmaceutical Companies; Biotech; Health Care; Entrepreneur; Innovation; International Business; Entrepreneurial Finance; Entrepreneurship; Finance; Innovation Strategy; Venture Capital; Strategy; Cross-Cultural and Cross-Border Issues; Pharmaceutical Industry; Biotechnology Industry; Tokyo
Krieger, Joshua Lev. "Catalys Pacific." Harvard Business School Case 821-035, September 2020. (Revised January 2021.)
- March 2018
- Supplement
Sandra Brown Goes Digital (B): The Commitment Decision
By: Rosabeth Moss Kanter and Jonathan Cohen
Sandra Brown, a middle manager at a biotech company who has led internal and external movements for change over the last few years, faces a decision. Whether to continue to work for change at the company or move on to pursue new opportunities elsewhere, where her new... View Details
Keywords: Digital; Stakeholder Engagement; Managing Change; Career Path; Health Care Industry; Quality; Leading Change; Management; Organizational Change and Adaptation; Personal Development and Career; Decision Choices and Conditions
Kanter, Rosabeth Moss, and Jonathan Cohen. "Sandra Brown Goes Digital (B): The Commitment Decision." Harvard Business School Supplement 318-083, March 2018.
- 30 Nov 2020
- News